Also called personalized medicine, this evolving field makes use of an individual’s genes, lifestyle, environment and other factors to identify unique disease risks and guide treatment decision-making.
Masimo's MightySat Medical is the first FDA-cleared pulse oximeter available to consumers without a prescription, which could disrupt the market for the notoriously inaccurate at-home devices.
MediView’s technologies utilize AR to provide clinicians with 3D “X-ray vision” guidance during minimally invasive procedures and surgeries, while also offering remote collaboration.
Deep convolutional neural networks (CNNs) can be trained to predict sequence types for brain MR images, according to new research published in the Journal of Digital Imaging.
Regina Barzilay, PhD, a professor at the Massachusetts Institute of Technology, has been working closely with AI technologies to improve breast cancer care ever since she was diagnosed with the disease in 2014.
A lung cancer researcher from Dartmouth College has received a $1.5 million grant from the National Cancer Institute to build and validate machine leaning approaches to develop better, more personalized cancer treatments.
The combination of machine learning and ultrasound could help healthcare providers with the diagnosis of thyroid nodules, according to new findings published in JAMA Otolaryngology.
Biogen, a biotech company based in Massachusetts, is planning to seek approval from the FDA for an experimental drug that targets the underlying causes of Alzheimer’s disease.
Discussions about AI and radiology often focus on the researchers who help develop the algorithms and radiologists themselves. But a new analysis published in Academic Radiology shines a light on another key role in the implementation of AI: the imaging informaticist.
Deep learning neural networks can improve the detection of tuberculosis (TB) and provide health systems with considerable cost savings, according to new findings published in Scientific Reports.
Compensation for heart specialists continues to climb. What does this say about cardiology as a whole? Could private equity's rising influence bring about change? We spoke to MedAxiom CEO Jerry Blackwell, MD, MBA, a veteran cardiologist himself, to learn more.
The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals.
As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”
